Stocks
Eli Lilly and CompanyLLY
NYSEHealthcarePharmaceuticals$985.08+0.80%
A global pharmaceutical manufacturer focused on developing and commercializing medicines for diabetes, obesity, oncology, immunology, and neuroscience. Its rapidly growing GLP-1 franchise, including treatments such as Mounjaro and Zepbound, has made the company a central player in the weight‑loss an...
Market Cap: $929.3B52W Range: $623.78 – $1133.95
Congressional Interest in Eli Lilly and Company (LLY)
20 members of Congress have disclosed 50 trades in Eli Lilly and Company (LLY), a Healthcare company. The buy/sell breakdown shows 22 purchases versus 28 sales, indicating net selling pressure from lawmakers. All data is sourced from STOCK Act periodic transaction reports filed with Congress.
Total Disclosures
50
Unique Politicians
20
Buys
22
Sells
28
Who in Congress Is Trading LLY?
| Date | Politician | Type | Amount |
|---|---|---|---|
| 2022-03-29 | Josh Gottheimer | buy | $1K – $15K |
| 2022-03-16 | Josh Gottheimer | buy | $1K – $15K |